The firm is placing 7 million shares with a private investment partnership. It has not stated its intended use for the proceeds.
Cellular Dynamics International and Promega are embarking on a research collaboration to validate stem cell-based assays that can be used during drug development.
Researchers from the National Cancer Institute have developed an assay in mouse embryonic stem cells to distinguish between deleterious and neutral human BRCA1 mutations.
The World Health Organization has announced the members of its gene-editing committee, according to NPR.
DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.
The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.
In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.